Tranexamic acid for traumatic brain injury - Authors' reply. (2020)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)30529-8
PubMed Identifier: 32682480
Publication URI: http://europepmc.org/abstract/MED/32682480
Type: Journal Article/Review
Volume: 396
Parent Publication: Lancet (London, England)
Issue: 10245
ISSN: 0140-6736